Sign in or register to see full information and data.

Studies / CAVD 296

Overview

Study information

Network:CAVD
Grant Affiliation:Weiss: Protection by Neutralizing Antibodies
Strategy:Protein & peptide vaccines
Study Type:Pre-Clinical Non-NHP
Species:Rabbit
Stage:Assays Completed
Study Start Date:2008-09-24
Study Made Public:2011-06-21

Title

Comparative analysis of Cn54 gp140 immunogenicity at different antigen doses, in different adjuvants, and at different pH

Description

CAVD 296 is a rabbit study designed to assess carbopol at ph4 and ph7 compared to FCA/FIA and to optimize dose of antigen (Chinese clade C HIV-1 CN54).

Products

Saline (non-specific) CFA IFA ZM96 gp140 Carbopol (pH 4) Carbopol (pH 7)

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.